Get started
Author

Alessia Capone

Observed names: A. Capone, CAPONE, ALESSIA, Capone, A., Capone, Alessia
ORCID: 0000-0001-8639-356X
Observed ORCID: 0000-0001-8639-356X
OpenAlex ID: A5050948879
Transcriptional Regulators of T Helper 17 Cell Differentiation in Health and Autoimmune Diseases
2020 · Alessia Capone, Elisabetta Volpe · Frontiers in Immunology · 186
PDF
Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain
2020 · Gloria Donninelli, Inbar Saraf-Sinik, et al. · Journal of Neuroinflammation · 78
PDF
FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis
2018 · Manolo Sambucci, Francesca Gargano, et al. · Scientific Reports · 73
PDF
Assessment of T-cell Reactivity to the SARS-CoV-2 Omicron Variant by Immunized Individuals
2022 · Lorenzo De Marco, Silvia D’Orso, et al. · JAMA Network Open · 63
PDF
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses
2024 · Anna Morena D'Alise, Guido Leoni, et al. · Clinical Cancer Research · 53
PDF
Inhibition of the PI3K/AKT/mTOR signaling promotes an M1 macrophage switch by repressing the ATF3-CXCL8 axis in Ewing sarcoma
2022 · Ramona Palombo, Ilaria Passacantilli, et al. · Cancer Letters · 40
The RNA‐binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma
2020 · Valentina Panzeri, Isabella Manni, et al. · Molecular Oncology · 34
Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapy
2023 · Maria Luigia Carbone, Alessia Capone, et al. · Frontiers in Immunology · 32
PDF
Th17 and Th1 cells in systemic lupus erythematosus with focus on lupus nephritis
2022 · Raouia Fakhfakh, Zeineb Zian, et al. · Immunologic Research · 25
Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients
2019 · Alessia Capone, Manuela Bianco, et al. · Cells · 21
PDF
Caspase-8 as a novel mediator linking Src kinase signaling to enhanced glioblastoma malignancy
2022 · Claudia Contadini, Alessandra Ferri, et al. · Cell Death and Differentiation · 17
PDF
Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients
2022 · Maria Luigia Carbone, Gabriele Madonna, et al. · Scientific Reports · 13
PDF
Systems analysis of human T helper17 cell differentiation uncovers distinct time-regulated transcriptional modules
2021 · Alessia Capone, Chiara Naro, et al. · iScience · 12
PDF
MYC Upregulation Confers Resistance to Everolimus and Establishes Vulnerability to Cyclin-Dependent Kinase Inhibitors in Pancreatic Neuroendocrine Neoplasm Cells
2020 · Francesca Terracciano, Alessia Capone, et al. · Neuroendocrinology · 11
The RNA binding protein Sam68 controls T helper 1 differentiation and anti-mycobacterial response through modulation of miR-29
2018 · Elisabetta Volpe, Eleonora Cesari, et al. · Cell Death and Differentiation · 7
PDF
Abstract LB196: NOUS-PEV, a personalized cancer immunotherapy targeting neoantigens, induces long lasting, tumor infiltrating memory T cells
2023 · Oliver Bechter, Anna Morena D'Alise, et al. · Cancer Research · 5
Genetic diversity in the env V1-V2 region of proviral quasispecies from long-term controller MHC-typed cynomolgus macaques infected with SHIV SF162P4cy
2018 · Alessia Capone, Alessandra Lo Presti, et al. · Journal of General Virology · 3
Identification and Purification of Human Memory T Helper Cells from Peripheral Blood
2021 · Alessia Capone, Elisabetta Volpe · Methods in molecular biology · 2
Immune-Related Adverse Events in Patients with Melanoma Treated with B-RAF/MEK Target Therapy: Occurrence and Circulating Immune Cell Analysis
2026 · Alessia Capone, Maria Luigia Carbone, et al. · Cancers · 1
PDF
802P Nous-209 immunotherapy with pembrolizumab for microsatellite instability high (MSI-H) metastatic colorectal cancer, refractory to anti-PD-1: Phase II trial results
2025 · F.J. Ros Montana, E. Elez Fernandez, et al. · Annals of Oncology · 1
Data from Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses
2024 · Anna Morena D'Alise, Guido Leoni, et al. · 1
Colonic Polyp Regression After Nous-209 Cancer Immunotherapy: A Clinical Trial Case Report
2026 · Marina Crespo-Cruz, Manuel Rodriguez-Justo, et al. · Journal of Immunotherapy and Precision Oncology
222 Ex-vivo evaluation of the effects of laser-breakdown products from skin tattoo removal
2024 · A. Capone, B. Battistini, et al. · Journal of Investigative Dermatology
PDF
Supplementary Figure 1 from Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses
2024 · Anna Morena D'Alise, Guido Leoni, et al.
Supplementary Table 1 from Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses
2024 · Anna Morena D'Alise, Guido Leoni, et al.
PDF
Works count: 35
Citation count: 685
H-index: 12
I10-index: 14
Year
Topic
Type